Insider Transactions Reported by 23 Insiders of REGENERON PHARMACEUTICALS, INC.

Symbol
REGN on Nasdaq
Location
Tarrytown, NY

Insiders trading volume in the past year

REGENERON PHARMACEUTICALS, INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
GEORGE YANCOPOULOS Bd. Co-Chair, President & CSO, Director $804,491,660 31 Dec 2025
LEONARD S. SCHLEIFER Bd. Co-Chair, President & CEO, Director $493,538,603 31 Dec 2025
VAGELOS P ROY Director $444,337,350 03 Apr 2023
Neil E. Stahl EVP Research and Development $43,324,609 16 Dec 2024
Andrew Murphy EVP Research $36,987,995 09 Dec 2025
Joseph LaRosa EVP General Counsel and Secret $31,085,287 05 Dec 2025
Daniel P. Van Plew EVP & General Mgr, Industrial $25,799,983 09 Dec 2025
George L. Sing Director $25,592,884 02 Jan 2026
Robert E. Landry EVP Finance CFO $22,918,280 02 Feb 2024
Christopher R. Fenimore EVP Finance CFO $15,789,013 05 Dec 2025
Arthur F. Ryan Director $13,818,785 02 Jan 2026
Marion McCourt EVP Commercial $10,220,534 09 Dec 2025
Michael S. Brown Director $9,930,104 02 Jan 2026
Joseph L. Goldstein Director $5,173,843 02 Jan 2026
Christine A. Poon Director $4,028,388 -$4,252,745 -51% 02 Jan 2026
Jason Pitofsky VP Controller $3,949,052 -$280,766 -6.6% 05 Dec 2025
Marc Tessier-Lavigne Director $2,315,367 03 Jan 2023
Bonnie L. Bassler Director $1,362,400 -$1,770,000 -57% 07 Jan 2026
N. ANTHONY COLES Director $1,322,984 02 Jan 2026
Huda Y. Zoghbi Director $1,314,494 02 Jan 2026
Craig B. Thompson Director $598,199 02 Jan 2026
David P. Schenkein Director $465,437 02 Jan 2026
Kathryn Guarini Director $465,437 02 Jan 2026

Recent Insider Transactions by Companies or Individuals for REGENERON PHARMACEUTICALS, INC.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.